4
Changes in Ownership
Merck & Co., Inc. Filed Acc 0001127602-24-005191
Chairman, CEO & President sold 235,021 shares at an average $125.69 ($29,538,998)
- Chairman, CEO & President acquired 235,021 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Davis Robert M Chairman, CEO & President | 2024-02-13 | Option exercise | +41,509 | $75.36 | $3,128,118 | 389,835.76 | D |
| Davis Robert M Chairman, CEO & President | 2024-02-13 | Option exercise | +108,491 | $73.73 | $7,999,041 | 498,326.76 | D |
| Davis Robert M Chairman, CEO & President | 2024-02-13 | Sale | −124,676 | $125.74 | $15,677,147 | 373,650.76 | D |
| Davis Robert M Chairman, CEO & President | 2024-02-13 | Sale | −25,324 | $126.37 | $3,200,277 | 348,326.76 | D |
| Davis Robert M Chairman, CEO & President | 2024-02-14 | Option exercise | +85,021 | $73.73 | $6,268,598 | 433,347.76 | D |
| Davis Robert M Chairman, CEO & President | 2024-02-14 | Sale | −85,021 | $125.40 | $10,661,574 | 348,326.76 | D |
| Derivatives | |||||||
| Davis Robert M Chairman, CEO & President | 2024-02-13 | Option exercise · Stock Option (Right to Buy) | −41,509 | 83,020 | D | ||
| Davis Robert M Chairman, CEO & President | 2024-02-13 | Option exercise · Stock Option (Right to Buy) | −108,491 | 181,781 | D | ||
| Davis Robert M Chairman, CEO & President | 2024-02-14 | Option exercise · Stock Option (Right to Buy) | −85,021 | 96,760 | D | ||
| Open-market sales · 235,021 sh · avg $125.69 · $29,538,998 | |||||||
Loading xslF345X05/form4.xml…